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Summary
Human restingBlymphocytes enter a stateof sustained proliferationwhen incubatedwith both
mouse fibroblasticLcells stably expressingFcyRII/CDw32 and anti-CD40 antibodies . We have
explored the effects of 11 recombinant human cytokines (CKs) on induced cell proliferation and
immunoglobulin (Ig) production. Interleukin 4 (IL4) was the only CK able to enhance anti-
C1340-induced B cell multiplication as measured by enumeration of viable cells, and interferon
y (IFN-y) further stimulated this induced proliferation . IL4 enhanced the production ofIgM
and IgG by B cells and induced them to produce IgE. Combinations of114 and 11,2 resulted
in the production of large amounts of IgM and IgA . Interestingly, IFN-'y did not inhibit the
production ofIgEby cells stimulated with anti-CD40 andIL4. None of the tested CK combinations
resulted in theproduction of large quantities ofIgG . Therefore, this newculture system represents
a unique model to study isotype regulation in highly purifiedhumanB lymphocytes, in addition
to allowing the generation of long-term factor-dependent human B cell lines.
T
he maturation ofresting Blymphocytesinto Ig-secreting
cells is a highly regulated phenomenon, thought to be
coupled to considerable proliferation, which requires the par-
ticipation of antigen (Ag),' T cells, and probably accessory
cells (3) acting through cell-cell interactions via specificmem-
brane Ags and through the release of cytokines (CKs) . An
approach to understanding thephenomenainvolved in B cell
activation hasbeen made possible through the availability of
polyclonal activators includingantibodies to surfaceAgs (4)
and recombinant CKs (3) . These studies have shown that
antibodies againstthe B cellAg receptors (sIg) as well as other
non-Ig molecules can deliver activation signals to B cells. In
particular, theCD40 molecule has recently emerged as afunc-
tionally importantB cell surface Ag (5, 6) . The CD40 Ag
is a 277-amino acid glycoprotein whose 172-amino acid ex-
tracellulardomain has homology with thenervegrowth factor
receptor (7) and the55- and80-kDTNF receptors (8) . Soluble
anti-CD40 strongly enhances [3H]TdR uptake in costimu-
latedB cells and activates resting B cells as determined by
cell size increase (5, 6) . More recently, we have shown that
anti-CD40 antibodies presented on irradiated transfected L
cells stably expressing FcyRII/CDw32 induce a strong and
long-lasting proliferation of human B lymphocytes, which
allowed us to generate factor-dependent humanB cell lines
free of EBV infection (9) .
1 Abbreviations used in this paper . Ag, antigen ; CK, cytokine; GM, granu-
locyte/macrophage; rh, recombinant human .
Part ofthis work has been presented in Abstract forms at the 1990UCLA
Symposium on B lymphocyte development, March 31-April 6, Park City,
UT (1, 2).
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Thepresent work is aimed at studying the effects ofmany
differentrecombinant CKs on the proliferation andIg produc-
tion ofhumanB cells activated with anti-CD40. We show
that 114 is the soleCK able to boost theanti-CD40-induced
expansion ofB lymphocytes and that IFN-y enhances this
effect . Furthermore, IL4 inducesanti-CD40-activatedBcells
to produce IgE, and combinations of 114 and I1r2 induce




The anti-CD40mAb 89 was produced in the labo-
ratory (6) . The CDw32/FcyRII-transfected Ltk - cell line
(CDw32 L cells) waskindly provided byDr.K. Moore (DNAX,
Palo Alto, CA) (10) . Cell phenotype wasdetermined using FITC-
conjugated mAbs originating from Becton Dickinson&Co. (Moun-
tain View, CA) . The F(ab')2 fragments of goat anti-human IgD
andIgMwere from KallestadLaboratories, Inc. (Austin, TX). Cul-
tures were carried out in modified Iscove's medium as detailed pre-
viously (11) .
Cell Preparations and Cell Cultures.
￿
B cells were isolated from
tonsils as described earlier (12) . The isolated population expressed
>98% CD19 or CD20 (B cells) and<1% CD2 (T cells) or CD14
(monocytes). Proliferation assays wereperformed in 96-wellV -shaped
microtiter plates (CEB, Nemours, France) in which 2.5 x 10 3 ir-
radiated (7,000 rad) CDw32 L cells were added . 2.5 x 10° puri-
fied B cells were then added to cultures. Cells were pulsed with
1 pCi ['H]TdR usually at day3 and 7. [3H]TdR uptake was mea-
suredby standard liquid scintillation counting techniques after har-
vesting. In most experiments, 5 x 105 B cells in 1 ml were cul-
tured on 2.5 x 10' irradiated CDw32 L cells in 24-well plates,
for Ig production. Supernatants were harvested after 10 d and Ig
levels were determined by ELISA . Ig levels were also determined
in the supernatants of cells that had been split at various time in-
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in standard ELISA as described elsewhere (11) .
Cytokines .
￿
Each of the tested CKs was used over a wide range
of concentrations . Purified recombinant human (rh) II,1a (108
U/mg) was purchased from Genzyme (Boston,MA) and was usu-
ally used at 25 U/ml (2.5-150 U/ml) . Purified rhIL2 (3 x 106
U/ml) and rhIFN-y (107 U/mg) were purchased from Amgen
Biologicals (Thousands Oaks, CA) and were, respectively, used at
20 U/ml (1-50 U/ml) and 500 U/ml (25-1,250 U/ml) . Purified
rhIL5 was provided byR. Coffman (DNAX) . It was usually used
at 15 ng/ml, which represents five times the concentration required
for optimal growth and differentiation of human eosinophil
precursors . Purified rhII,3 (5 x 106 U/mg) and granulocyte/mac-
rophage (GM)-CSF (2 x 10 6 U/mg) were'provided by S. Tindall
(Schering-Plough Research, Bloomfield, NJ) and were usually,
respectively, used at 10 ng/ml (1-50 ng/ml) and 100 ng/ml (10-250
ng/ml), which were saturating for the growth of hematopoietic
precursors in liquid cultures or in colony assays performed in semi-
solid medium. Purified rhIL4 (derived from Escherichia coli ; 107
U/mg) was provided by P. Trotta (Schering-Plough Research) . In
most experiments, 11,4 was used at 100 U/ml (0.1-1,750 U/ml),
which provides maximal stimulation ofB cell growth in these cul-
ture conditions .
Purified E . coli-derived rhIFNa2b (2 x 109 U/ml ; Schering-
Plough Research) was usually used at 250 U/ml (50-1,000 U/ml) .
Purified rhTNF-a (2 x 107 U/mg; Genzyme) was usually used
at 5 ng/ml (1-20 ng/ml) . Purified rhIIx6 (10 7 U/mg ; Genzyme)
was usually used at 5 ng/ml (0.25-25 ng/ml) .Human 11,7, purified
from Cos 7 supernatant, was provided by F. Lee and J . Wideman
(DNAX) . It was usually used at 25U/ml (1-100 U/ml), one unit
being defined as the concentration inducing the half-maximal
proliferation of the murine pre-B clone K .
Results
Proliferation of Anti-CD40-activated B Cells in Response to
CKs . To study whetherCKs would costimulatewith cross-
linked anti-CD40 to induceB cell proliferation, purified resting
B cells were cultured onCDw32L cells with 0.5 pg/ml mAb
89 with or without 11 different recombinant CKs, each of
them used at various concentrations. [3H]TdR uptake was
measured at day 3 and 7 . Results illustrated in Fig. 1 were
pooled from several independent experiments performed under
exactly the same conditions (at day 7) and show the CK con-
centration that was found to be optimal in this assay. Results
obtained with IL4 alone represent the mean of 23 different
experiments performed over an 18-mo period. The otherCKs
used alone or in combination with IL4 have been tested in
three to five independent experiments. As illustrated in Fig.
1 A, IL4 strongly potentiated B cell proliferation . As shown
in Fig. 2 A, the 1L4-induced [ 3H]TdR uptake was optimal
at -100 U/ml, but concentrations as low as 2.5 U/ml dis-
played significant activity. IL1ca, 11,6, and IFN- ,y were also
found to enhance [3H]TdR uptake, but it was always lower
than that observed in IL4 . Their proliferative effects were
dose dependent and were maximal at, respectively, 25 U/ml,
2 ng/ml, and 250 U/ml (data not shown) . IL2 and IL3 also
weakly enhanced [3H]TdR uptake, but I1,5, 11,7, TNF-ca,
GM-CSF, and IFN-a2b did not.
As 11L4 was reproducibly a strong enhancer of B cell growth,
we tested whether the otherCKswould modulate its effects.
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Figure 1 .
￿
Proliferative response of anti-CD40-activated B lymphocytes
to CKs. 2 .5 x 104 purified B lymphocytes were seeded on 2 .5 x 103 ir-
radiatedCDw32 L cells with 0 .5 wg/mlmAb 89 with or without recom-
binant CKs. (A) Effect of a singleCK on the mAb 89-induced prolifera-
tive. (B) Effect ofa CK on the proliferation induced by the combination
ofmAb 89 and IIr4 . [3H]TdR uptake was measured at day 7 . Results are
pooled from different experiments (23 experiments for 0 and IIA; three
to five for other CKs) . [3H]TdR uptake of B cells cultured with mAb
89 without (A) or with (B) IL4 was considered as the 100% value for
each experiment, and the stimulation index for a givenCK was calculated
as the ratio ofcpm values obtained with the combination mAb 89 + CK
± 11,4 vs. mAb 89 ± IIA . 11 .1a = 25 U/ml ; IL2 = 20 U/ml; IL3
= 10 ng/ml ; IL4 = 100 U/ml ; 11,5 = 15 ng/ml ; 11,6 = 5 ng/ml ; IIT7
= 25 U/ml; TNF-a = 5 ng/ml ; GM-CSF = 100 ng/ml ; IFN-a2b =
500 IU/ml ; IFN- ,y = 250 U/ml .
Ma and IFN-,y enhanced the [3H]TdR uptake induced by
IL4 (Fig. 1 B), andmaximum stimulation was obtained with
25 and 250 U/ml, respectively. IL2,1W, and IL6 also slightly
stimulated the [3H]TdR uptake induced by the combination
of IL4 and anti-CD40 but were less efficient than 11,1ca or
IFN-y . All the other double CK combinations have been
tested and the proliferation did not exceed those obtained with
the most active CK of the pair (data not shown) .
Combinations of IL4 and anti-CD40 resulted in a 30-40-
fold increase of the input B cells after 21 d . Whereas 11,101
only marginally enhanced the increase ofB cells obtained with
11,4 and anti-CD40, IFN-,y further stimulated cell multipli-
cation, and combinations of anti-CD40, IL4, and IFN-y707
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Figure 2 .
￿
1114 induces anti-CD40-activated B cells to proliferate and
produce Ig . (A) B cell proliferation: 2.5 x 10 4 purified spleenB cells were
cultured for7 d on 2.5 x 10 3 irradiated CDw32L cells with0.5 /Ag/ml
mAb 89 and increasing concentrations of IIr4 . Cells were pulsed with
[3H]TdR for 16 h . Results aremeans ± SD of triplicates . (B) Ig produc-
tion: 5 x 105 B cells were seeded on 2.5 x 10 4 irradiated CDw32L cells
without orwith increasing concentrations of IL4 . Supernatants were har-
vested after 10 d and Ig levels were measured by ELISA . Representative
ofthreeexperiments : (/)IgG (left ordonates) : (*) IgE (right ordonates)




Cytokine-induced Production of Igs by Anti-CD40-activated B Lymphocytes
Table 2 .
￿
IL-4 and Anti-CD40-dependent Normal Human
B Cell Lines Produce Igs
105 purified B cells were cultured in 500 ul on 2.5 x 104 irradiated
CDw32 L cells in the presence of0.5 JAg/ml mAb 89 without or with
100 U/ml IL-4 . Cell cultures have been split at the indicated times and
105 cells were seeded on new CDw32 L cells and new medium . Ig levels
in supernatants were determined by ELISA. Results are means of Ig levels
in duplicate cultures. Cells cultured without IL-4 did not grow beyond
14 dand Ig levels were therefore not determined . Data are representative
of five experiments.
resulted in a 80-90-fold expansion ofinputB cells (not shown) .
All the cells expressed, after 18 d, CD19, CD20, CD21, CD24,
CD37, and HLA DR, but did not express CD3, CD4, or
CD8 (data not shown) .
Ig Production of B Cells Activated by Anti-CD40 and
CKs.
￿
Purified B cells, seeded on CDw32 L cells, with or
Ig levels
105 purified B cells were cultured in 500 I,1 on 2.5 x 104 irradiated CDw32 L cells in the presence of 0.5 kg/ml mAb 89 without or with 100
U/ml IL-4 without or with the indicated CK . Supernatants were harvested after 10 d and Ig levels were determined by ELISA. Results are means






Day 7 - 10 <5 <10 <0.2
+ 630 8 40 18
Day 14 - 60 <5 - <10 <0.2
+ 950 10 1,000 >30
Day 17
+ 450 30 40 >30
Day 21
+ 875 30 400 13
Ig IL-4 0 IL-1 IL-2
ng/ml
IL-5 IL-6 IFN-y
M 0 43 82 345 179 20 122
+ 1,194 698 11,856 420 520 964
G 0 433 330 637 402 602 578
+ 649 430 902 491 370 1,088
A 0 185 160 281 247 155 248
+ 276 520 2,500 863 118 1,115
E 0 <0.3 <0.3 <0.3 <0.3 <0.3 <0.3
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Combinations of IL2 and IIA induce anti-CD40-activated
B cells to produce IgM and IgA . 5 x 10 5 purified B cells were cultured
on 2.5 x 104 irradiated CDw32 L cells in the presence of0 .5 Ag/mlmAb
89 and increasingconcentrations of114 ([Ql no 11,4 ; [* 110 U/ml ; [" ]
50 U/ml ; [01250 U/ml) and 11,2 . Supernatants were harvested after 10 d
and Ig levels were measured by ELISA . (A) IgM; (B) IgA . Data are repre-
sentative of two experiments .
without mAb 89, and with or without recombinant CKs,
were tested for their ability to produce Igs . As illustrated in
Table 1, crosslinking of CD40 did not result in significant
Ig production, although supernatants of cells cultured with
mAb 89 contained a few-fold more IgM and IgG than those
of cells cultured without mAb 89 . ILlcx, IL-2, IL-3, IL5,
IL6, and IFN-y only marginally altered Ig production . How-
ever, IL4 consistently stimulated IgM and IgG production .
The most striking finding was the IL4-induced production
of IgE . As shown in Fig. 2 B, the 1174-induced increase of
Ig production was dose dependent, and the plateau was ob-
tained for -100 U/ml IL4 for all three isotypes (data not
shown, for IgM) . The concentration of IL-4 inducing a half-
maximal response was practically the same for the three iso-
types (-10 U/ml for IgG and IgM; -40 U/ml for IgE) .
B cells cultured for 21 d with anti-CD40 and 11,4 continu-
ously produced the four isotypes (Table 2) .
We also tested whether the IL4-induced Ig production could
be modulated by other CKs (Table 1) . ILlct, IL-3, IL-5, IL6,
and IFN-y only weakly modulated Ig production induced
by 114 . Note in particular the lack of inhibitory effect of
IFN-y on IL4-induced IgE production . Most interestingly,
combinations of IL2 and 1174 resulted in production ofIgM
and IgA . As shown in Fig. 3, the induced IgM and IgA




Anti-CD40 Activation of B Lymphocytes
Recently, we have reported that anti-CD40 antibodies
presented on FcyRII/CDw32-transfected L cells can induce
the proliferation of resting B lymphocytes (9) . This system
is unique in that it is the first one that allows an increase
of the total number of seeded human B cells . The present
study was aimed at determininghowCKs affect the prolifer-
ation and dilerentiation of these anti-CD40-activatedB cells .
Among 11 tested recombinant CKs (ILlce to 7, GM-CSF,
TNF-a, IFN-oz2b and IFN-y), only IIA was found to strongly
costimulate with anti-CD40 to induce B cell proliferation
as measured both by [ 3H]TdR uptake and cell counts . Un-
like what was previously demonstrated with anti-IgM-
activated B cells where IL4 appears to act as a short-term
growth factor (12), the activating property of IL4 on anti-
CD40-activated B cells was long lasting . ILlcac, IL6, and
IFN-y were found to enhance [3H]TdR uptake, but the
effect was not sufficient to result in increased cell counts .
IFN-y, and to a lesser extent ILla, were found to enhance
B cell proliferation induced by IL4 and anti-CD40 . The
stimulatory effect of IFN-y on IL4/anti-CD40-induced B
cell proliferation is in accordance with our earlier results
showing that IFN-y enhances the IL-4-induced proliferation
ofB cells costimulated with anti-IgM with or without IL4
(12, 13) . It is worth pointing out that IL5 failed to enhance
the proliferation of anti-CD40-activated B cells and, there-
fore, in contrast to murine IL-5 (14), human IIT5 has never
scored positive in any of the assays measuring B cell prolifer-
ation (15) . Likewise, TNF-a and IFN-oz failed to induce the
proliferation of anti-CD40-activated B cells, whereas they have
been shown to induce the proliferation ofB lymphocytes ac-
tivated through their Ag receptors (16, 17) . Also of interest
is the virtual lack of growth-promoting activity of IL-2 on
anti-CD40-activated B cells, whereas it is at least as potent
and often more potent than IL4 in inducing [ 3H]TdR up-
take in B cells stimulated with anti-IgM or Staphylococcus aureus
Cowan (18) . IL3 was found repeatedly to provide a small
proliferation signal to anti-CD40-activated B cells, whichwe
also found with B cells costimulated with anti-IgM (T
Defrance and J. Banchereau, unpublished observations) . Fi-
nally, as observed with B cells stimulated through their Ag
receptor, IL-7 and GM-CSF were unable to induce the prolifer-
ation of anti-CD40-activated B cells.
B cells activated with anti-CD40 were found to produce
relatively little IgM, IgG, and IgA . Whereas IL1a, IL2, 11,3,
IL5, IL6, and IFN-y did not enhance the Ig production of
proliferating B cells, 11,4 was able to enhance IgM and IgG
production and to induce the production of large amounts
ofIgE. This contrasts with previous studies showing the neces-
sary role ofT cells and monocytes in IL4-induced differenti-
ation ofB cells to IgE production (19-21) . However, a direct
capacity of IL4 to induce purified human B cells to produce
IgE was recently described (22) where combined addition
of EBV and IL4 results in EBVtransformed B cell lines
producing IgE . In our present system, we have been able to
rule out a possible role for EBV by various means (9) . The
half-maximal concentrations of IL4-inducing production of
IgM, IgG, and IgE were similar. This contrasts with the con-centrations of 114 required to induce LPS-activated murine
B cells to produce IgE that are higher than those necessary
to induce IgG (23) . Interestingly, IFN-y appears unable to
inhibit the 114-induced IgE production by anti-CD40-
activated human B cells, at variance with the EBV system
(22), where IFN-y can block the IL4-independent generation
ofIgE-producingEBV cell lines . It also differs from the IL-4-
induced IgE production by mouse LPS-activatedB cells, which
is also inhibited by IFN-y (24) . The lack of inhibitory ac-
tivity of IFN-y in I1,4-induced IgE production has, how-
ever, been observed with cord blood B cells (25) . Taken to-
gether, these data suggest that IFN-ymay inhibit I174-induced
IgE production by adult mononuclear cells in an indirect
fashion . Our present observation suggests that triggering of
CD40may represent an important event in the 11,4-induced
IgE production . It remains to be established whether the ob-
served production of IgE results from the expansion of IgE-
committedB cells or from an IL4/anti-CD40-induced switch .
We presently favor the latter hypothesis, as preliminary ex-
periments have shown that naive IgD' B cells do indeed
produce IgE under these culture conditions . Our present
finding raises the question as to whether the IgE production
observed in an allogeneic T-B cell interaction (21, 26, 27) or
in the 114 activation of mononuclear cells (19, 20, 27) in-
volves triggering of the B cell CD40 Ag.
The combination of IL4 and IL-2 resulted in a strongIgM
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To conclude, this work shows that the combination of
IFN-y and IL-4 is, at the present time, the most potent one
to induce the expansion of B cells activated through their
CD40 Ag . Furthermore, it shows that anti-CD40-activated
purified B cells produce IgE in response to 11,4 and that the
further addition of11,2 induces cells to secrete large amounts
of IgA and IgM . Therefore, this new system represents a
unique model to study isotype regulation in highly purified
humanB lymphocytes . Finally, the dramatic effects ofCD40
ligation on B cell function make it important to determine
the nature of the CD40 ligand, particularly since the CD40
Ag has been shown to display an important homology with
nerve growth factor receptor (7) and TNF receptors (8) .
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